The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
The DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [104]
In the citing paper
“Another drawback of long-term antidepressant treatment is concerned with the serious and bothersome side effects that may ensue with SSRI and SNRI, such as high rates of sexual dysfunction, bleeding (in particular gastrointestinal), weight gain, risk of fracture and osteoporosis, and hyponatremia.73”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [73]
In the citing paper
“Examples are switching from unipolar to bipolar course with antidepressant drugs [6,31] and supersensitivity psychosis, the onset of psychotic symptoms and co-occurring movement disorder with antipsychotic medications [4].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“For instance, several side effects of antidepressants are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“Since gastric symptomatology did not follow the somatic patterns typical of anxiety disturbances, venlafaxine was also suspected as a iatrogenic cause [6].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, Jr., Hardy, R., Lewis, G., & Mason, J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 86
RetractedProjections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Research works printed but not linked: 2
- 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
- 10.1210/endo.133.2.8344205 · doi:10.1210/endo.133.2.8344205 · Paper page
Cited by
Items 401–500 of 654
Tripathi, A., Agrawal, A., & Joshi, M. (2024) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_784_23 · Cited by 4
Brišnik, V., Rottenkolber, M., Vukas, J., Schechner, M., Lukaschek, K., Jung‐Sievers, C., Gensichen, J., Thiem, U., Drey, M., Krüger, N., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03584-9 · Cited by 7
Poor muscle health and cardiometabolic risks associated with antidepressant treatment
Andersson, P., Linge, J., Gurholt, T. P., Sønderby, I. E., Hindley, G., Andreassen, O. A., & Leinhard, O. D. (2024) · Obesity · doi:10.1002/oby.24085 · Cited by 4
Zurchimitten, G., Camerini, L., Izídio, G. S., & Ghisleni, G. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111154 · Cited by 6
Drug-drug-interactions in patients with atrial fibrillation admitted to the emergency department
Bischof, T., Nagele, F., Kalkofen, M. M., Blechschmidt, M. E. O., Domanovits, H., Zeitlinger, M. A., Schoergenhofer, C., & Cacioppo, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1432713 · Cited by 4
Depression-related innate immune genes and pan-cancer gene analysis and validation
Yang, Y., Han, W., Zhang, X., Yuan, H., Wang, R., Yang, J. Y., An, C., & Huang, D. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2024.1521238 · Cited by 4
Dobrea, C. M., Morgovan, C., Frum, A., Butucă, A., Chiş, A. A., Arseniu, A. M., Ghibu, S., Vonica, R. C., Gligor, F. G., Ilie, I. R. P., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041208 · Cited by 5
A pharmacovigilance study of vortioxetine based on data from the FDA adverse event reporting system
Liu, M., Yang, X., Long, W., Han, X., & Xiong, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-13786-7 · Cited by 4
Ghasemi, M., Yaraghi, A., Farajzadegan, Z., Sabzghabaee, A. M., & Eizadi‐Mood, N. (2018) · Advanced Biomedical Research · doi:10.4103/abr.abr_132_18 · Cited by 4
Ravi, P. V., Maharajan, A., Pattabiraman, A., & Pichumani, M. (2023) · Diamond and Related Materials · doi:10.1016/j.diamond.2023.110407 · Cited by 4
Papel de vortioxetina en el tratamiento del dolor neuropático
Montero, A. A., & de Vasconcelos, S. R. P. (2021) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2021.04.001 · Cited by 4
Hofferer, A., Dolladille, C., Chrétien, B., Sassier, M., Laugier, D., Atzenhoffer, M., Bagheri, H., Alexandre, J., Fédrizzi, S., & Humbert, X. (2021) · L Encéphale · doi:10.1016/j.encep.2021.04.009 · Cited by 4
Fava, G. A. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001468 · Cited by 4
Self-citationWang, Y., Li, Y., Ji, Z., Han, F. L., Yang, D., & Lv, C. (2021) · Sustainability · doi:10.3390/su14010059 · Cited by 5
Belau, M. H., Wiessner, C., Becher, H., von Rüden, U., & Briken, P. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.03.610 · Cited by 4
Espinola, C. W., Khoo, Y., Parmar, R., Demchenko, I., Frey, B. N., Milev, R. V., Ravindran, A. V., Parikh, S. V., Ho, K. T., Rotzinger, S., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221095832 · Cited by 6
Liu, S., Tong, Y., Wang, X., Yu, X., & Xu, Y. J. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01475-9 · Cited by 6
Gutiérrez, L., Pérez, A. M. L., Catalá, P., Écija, C., Collado‐Mateo, D., Gil-Arias, A., & Peñacoba, C. (2023) · Applied Sciences · doi:10.3390/app13021191 · Cited by 7
Lethal vortioxetine poisoning? A forensic investigation
Zuccarello, P., Carnazza, G., Giorlandino, A., Cosentino, S., Arcifa, V., & Barbera, N. (2023) · Legal Medicine · doi:10.1016/j.legalmed.2023.102314 · Cited by 5
Freeman, M. P. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3637 · Cited by 6
The Role of Psychological Interventions in the Maintenance Treatment of Depression
Schramm, E., Elsaeßer, M., & Guidi, J. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000522014 · Cited by 4
Antidepressant Efficacy in Managing Nonspecific Chronic Lower Back Pain Among Older Adults: A Review
Wilczyński, K., Mazurski, A., & Kotucha, K. (2024) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2024.2384961 · Cited by 5
Chen, Y., Yang, S., Shi, H., Cui, J., & Zhu, L. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70408 · Cited by 5
Fakorede, S., Peters, J., Murphy, T., Troung, E., & Abou, L. (2025) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2025.2518261 · Cited by 5
Zhai, Y., Wu, L., Zheng, Y., Wu, M., Huang, Y., Huang, Q., Shentu, J., Zhao, Q. D., & Liu, J. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s258173 · Cited by 3
Economos, G. P. S., Alexandre, M., Perceau-Chambard, É., Villeneuve, L., Subtil, F., Haesebaert, J., & Gléhen, O. (2022) · BMC Palliative Care · doi:10.1186/s12904-022-00976-7 · Cited by 4
Vittengl, J. R., Jarrett, R. B., Ro, E., & Clark, L. A. (2023) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-230016 · Cited by 3
Ethics of Non-invasive Neuromodulation in Psychiatry
Buthut, M., Chandler, J. A., Bublitz, C., & Soekadar, S. R. (2025) · The International Library of Bioethics · doi:10.1007/978-94-024-2274-0_25 · Cited by 4
Recovery of visual scotomas by vortioxetine in a patient with symptomatic occipital lobe epilepsy
Önder, H., Coşkun, A., & Goksungur, M. (2018) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_291_17 · Cited by 3
Wu, L., Xu, C., Wu, G., Zhou, H., Lv, D., Zhai, Y., Huang, Y., Tang, W., Li, F., & Shentu, J. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s207561 · Cited by 3
Asphyxia risk factors in adult psychiatric wards
Sugisawa, S., Nozue, S., Kurihara, T., Koya, H., Tsuneoka, T., Nagai, T., Kurata, N., Inamoto, A., Takahashi, K., & Sasaki, T. (2020) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12487 · Cited by 3
Para qué indicaciones se están utilizando los antidepresivos en adultos de Colombia
Marín-Rincón, H. A., Machado‐Duque, M. E., & Machado‐Alba, J. E. (2020) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2020.11.004 · Cited by 3
Janjua, K. A., Garcia, J. H., & Baweja, R. K. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001422 · Cited by 3
He, D., & Xu, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7889199 · Cited by 3
Kim, D.-W., Kwon, H.-W., & Kim, S.-H. (2023) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2023.101769 · Cited by 3
Opção terapêutica para ansiedade: o uso da Cannabis sativa é uma alternativa farmacológica?
Bueno, A. R., & Ortiz, J. V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i15.22948 · Cited by 9
Antimisiaris, D. E., McHolan, B., Moga, D. C., & Mospan, C. M. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.68 · Cited by 4
A case of venlafaxine-induced angioedema in an older adult
Griffin, H., Pearson, S. M., Linnebur, S. A., & Fixen, D. R. (2021) · SAGE Open Medical Case Reports · doi:10.1177/2050313x211050465 · Cited by 3
Antidepressants in people with epilepsy: A double-edge sword!
Calabrò, R. S., Manuli, A., Portaro, S., Naro, A., & Quattrini, F. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.11.038 · Cited by 3
Depression screening in pregnancy and postpartum: Just do something?
Thombs, B. D., Rice, D. B., Markham, S., & Ziegelstein, R. C. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.02.005 · Cited by 4
Naseralallah, L. M. A., Noureddine, Z., & Koraysh, S. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70041 · Cited by 2
Seifert, J., Bleich, S., & Seifert, R. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_22 · Cited by 3
Liu, Z., Wang, Q., Li, X., Zhao, Y., Liu, W., Guo, Q., & Yuan, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120308 · Cited by 4
Trimm, K., Moraga, M.-T., Knaüper, B., Rahme, E., McDonald, E. G., & Tamblyn, R. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01476-1 · Cited by 3
Christoforou, L., & Sutcliffe, K. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13445-7 · Cited by 2
Dell’Osso, B. M., Blasi, G., Serafini, G., Serrati, C., Bianchetti, A., Porto, I., Forleo, G. B., Pugliese, A., Mastrostefano, A., & Nicoletti, F. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2602193 · Cited by 2
Figueiredo, I., Bicker, J., Vitorino, C., & Fortuna, A. C. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2668677 · Cited by 2
O uso de antidepressivos na gestação
Dotto, B. S., & Bó, S. D. (2022) · Inova Saúde · doi:10.18616/inova.v13i2.6155 · Cited by 2
Depression and Other Neuropsychiatric Issues Following Stroke
Jones, M. B., & Jorge, R. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55381-0.00011-1 · Cited by 3
Jung, M. H., Lee, J. G., Bahk, W., Woo, Y. S., Wang, S., Jeong, J., Kim, W., Shim, S.-H., Seo, J. S., Jang, S.-H., et al. (2021) · 신경정신의학 · doi:10.4306/jknpa.2021.60.4.267 · Cited by 2
Does Long-Term Post-Bariatric Weight Change Differ Across Antidepressants?
Arterburn, D. E., Maciejewski, M. L., Berkowitz, T. S. Z., Smith, V. A., Mitchell, J. E., Liu, C., Adeyemo, A., Bradley, K. A., & Olsen, M. K. (2022) · Annals of Surgery Open · doi:10.1097/as9.0000000000000114 · Cited by 2
Physical Comorbidities and Mood Disorders in Older Adults
Dols, A., & Sonnenberg, C. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-2414-6_15 · Cited by 2
The impact of nonmotor symptom burden on sexual function
Staunton, J., Jost, S. T., Bronner, G., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2021.12.007 · Cited by 2
Anticonvulsant and Proconvulsant Effects of Trazodone in Different Seizure Models
Luo, W., Liu, W., Huang, Y., & Deng, X. (2022) · International Journal of Pharmacology · doi:10.3923/ijp.2022.1474.1481 · Cited by 2
Wu, X., Tu, M., Chen, N., Yang, J., Jin, J., Qu, S., Xiong, S., Cao, Z., Xu, M., Pei, S., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1181947 · Cited by 2
Are Newer Drugs Better? An Analysis of Neonatal Pharmacological Treatments across Generations
Lai, N. M., Veettil, S. K., Chaiyakunapruk, N., & Glasziou, P. (2024) · Medical Principles and Practice · doi:10.1159/000539729 · Cited by 2
Obesity‐associated factors in psychiatric outpatients: A multicenter questionnaire survey
Ishii, H., Yamada, H., Sato, R., Hayashi, W., Nakamura, D., Sugita, S., Tazaki, T., Takashio, O., Inamoto, A., & Iwanami, A. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12465 · Cited by 2
Use of Antidiabetic, Antihypertensive, and Psychotropic Drugs in Pregnancy
Fasanella, D. R., Luttrell, S. E., Tejada, F. R., Ngokobi, H., & Ayuk-Tabe, M. (2018) · Side effects of drugs annual · doi:10.1016/bs.seda.2018.07.005 · Cited by 4
Huang, X., Yin, H., Wan, X., Fu, B., Tang, B., & Lei, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.001 · Cited by 4
A Narrative Review on Dialectical Behavior Therapy for Patients with Depressive Difficulties
Saini, A. K., Wal, P., Wal, A., Pal, R. S., & Verma, O. P. (2022) · Current Psychiatry Research and Reviews · doi:10.2174/2666082218666211220153312 · Cited by 2
Uebelacker, L. A., Epstein-Lubow, G. P., Sillice, M. A., O’Keeffe, B., Kraines, M. A., Battle, C. L., Anderson, B. J., Miller, I. W., & Abrantes, A. M. (2023) · Mental health and physical activity · doi:10.1016/j.mhpa.2023.100508 · Cited by 5
The interplay of psychopharmacology and medical conditions
Serretti, A. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000512 · Cited by 2
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine
Mutlu, O. A., Kavla, Y., & Demirel, Ö. F. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001482 · Cited by 2
Explaining Depression in Clinical Settings: Shortcomings and Dangers of Simplified Analogies
Schultz, W. (2017) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.19.1.51 · Cited by 3
Hirano, Y. (2018) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479018808248 · Cited by 2
Lievesley, R. (2019) · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository) · Cited by 5
Reboxetine in the light of science and clinical practice
Wasik, A., & Siwek, M. (2019) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2019.0009 · Cited by 1
Beneficios potenciales de vortioxetina en el tratamiento del dolor crónico
Montero, A. A., & de Vasconcelos, S. R. P. (2021) · Neurology Perspectives · doi:10.1016/j.neurop.2021.03.001 · Cited by 1
Effects of Antidepressant Agents on Cornea and Ocular Surface
Özer, Ö., & Güçlü, E. S. (2023) · Cukurova Anestezi ve Cerrahi Bilimler Dergisi · doi:10.36516/jocass.1229624 · Cited by 2
Diving with psychotropic medication: review of the literature and clinical considerations
Praktijk Querido, H., Querido, A. L., Dutch Society of Diving and Hyperbaric Medicine, B., Ebbelaar, C. F., Wingelaar, T. T., & Dutch Society of Diving and Hyperbaric Medicine, B. (2023) · Diving and Hyperbaric Medicine Journal · doi:10.28920/dhm53.3.259-267 · Cited by 6
The Effects of Gender and Age-Progressed Avatars on Future Self-continuity
Keane, E., & McDonnell, M. (2023) · Lecture notes in networks and systems · doi:10.1007/978-3-031-47457-6_4 · Cited by 1
Sexual Disorders in Females with Bipolar Disorder
El-Sorogy, S. E., El-Hamady, M. M., Mohamed, A. S., & Dahroug, M. M. M. (2024) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2024.275914.1354 · Cited by 1
Bech, C. F., Simonsen, J., & Hertzum, M. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105483 · Cited by 1
Analytical Methods for Tetracyclic Antidepressants: A Comprehensive Review
Shetty, S. R., Rathore, S. S. S., & Jenita⃰, J. J. L. (2024) · Separation Science Plus · doi:10.1002/sscp.202400157 · Cited by 1
Li, M., Zhuo, X., Liu, Y., You, J., & Lin, J. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03618-3 · Cited by 2
Zhang, J., Huang, S., Hu, C., Liao, C., Tang, Z., Li, N., Qian, Y., Luo, H., Tang, F., & He, Z. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.05.002 · Cited by 1
Kheirkhah, F., Hamzehkolaee, M. E., Parvizi, S., Khafri, S., Bijani, A., & Hamzehpour, R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04329-y · Cited by 1
Stassen, H. H., Bachmann, S., Bridler, R., Cattapan, K., Hartmann, A. M., Rujescu, D., & Seifritz, E. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02062-4 · Cited by 1
Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Rodríguez‐Landa, J. F., Puig-Lagunes, Á. A., & Soria-Fregozo, C. (2025) · Acta Pharmaceutica · doi:10.2478/acph-2025-0029 · Cited by 1
Siwek, A., Marcinkowska, M., Mordyl, B., Głuch‐Lutwin, M., Wolak, M., Jastrzębska‐Więsek, M., Wilczyńska-Zawal, N., Wyska, E., Szafrańska, K., Wesołowska, A., et al. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174128 · Cited by 1
Three Decades of SSRI/SNRI Withdrawal Research: A Bibliometric and Science-Mapping Study
Akça, E. (2025) · The European Research Journal · doi:10.18621/eurj.1825803 · Cited by 1
Ihsan, S., Halik, H., Sugiyanto, S., & Soewadi, S. (2025) · ad-Dawaa Journal of Pharmaceutical Sciences · doi:10.24252/djps.v8i2.58334 · Cited by 1
Stark, C., Beck, J., Oswald, A., Rogausch, A., Schreiner, A.-K., Cody, R., Hohberg, V., Knappe, F., Kreppke, J.-N., Ludyga, S., et al. (2026) · Trials · doi:10.1186/s13063-026-09500-1 · Cited by 1
A unifying theory of brain signaling and its possible role in acquired chronic disease
Pereira, G., Corbett, M., Vernon, S. D., Colburn, S., & Chanda, S. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1683413 · Cited by 1
Riaz, S., Khuda, F., Khan, A., Jan, A., Ibenmoussa, S., Alotaibi, G., Ali, S. S., & Albabtain, B. A. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-026-00644-7 · Cited by 1
Rahman, M., Akter, K., Rani, A., Park, M. N., & Kim, B. (2026) · Nutrients · doi:10.3390/nu18111796 · Cited by 2
Discontinuation, Medication Switching, and Augmentation After SSRI in Pediatric Depression
Lee, H. H., Castillo, W. C., Qato, D. M., Rose, R. A., Reeves, G. M., & dosReis, S. (2026) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2026.06.006 · Cited by 1
Parks, A. C., Woodward, A. L., Vlisides‐Henry, R. D., Arden, K., Vando, L., Swain, J., & Lamichhane, B. (2026) · Journal of Medical Internet Research · doi:10.2196/92647 · Cited by 1
Gao, Z., Chen, X., Yu, X., Hu, L., & Gao, C. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122443 · Cited by 1
Second generation antidepressants and the risk of arrhythmia
Suwalska, J., Napierała, M., Proch, M., Szymańska, I., Szydłowska, M., Szablewski, B., & Łojko, D. (2021) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2021.02.004 · Cited by 1
Thrombocytopenia due to escitalopram use – A rare case report at the emergency department
Bedel, C., & Korkut, M. (2021) · Iraqi Journal of Hematology · doi:10.4103/ijh.ijh_47_20 · Cited by 1
Antidepressant safe use, deprescription and switching guideline
Goñi, O. (2021) · Boletín de información farmacoterapéutica de Navarra · doi:10.54095/bitn20212904 · Cited by 3
The combined effect of psychodynamic psychotherapy and pharmacotherapy on healthcare cost
Yonatan‐Leus, R., Abargil, M., & Cooper‐Kazaz, R. (2022) · Psychotherapy Research · doi:10.1080/10503307.2022.2032861 · Cited by 1
Ciccone, C. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-60912-8.00006-3 · Cited by 3
The Development and Mechanism of Treatment of Depression
Chang, F., Kuang, X., & Liu, Y. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v8i.1120 · Cited by 1
Singh, L., & Bhatti, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-2302-1_13 · Cited by 1
Seifert, J., Bleich, S., & Seifert, R. (2023) · Springer eBooks · doi:10.1007/978-3-662-68371-2_22 · Cited by 2
CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS
Kaiserman, A., Vanderijst, L., & Kornreich, C. (2024) · Psychiatria Danubina · doi:10.24869/psyd.2024.174 · Cited by 2
Genetic determinants of antidepressant and antipsychotic drug response
Stassen, H. H., Bachmann, S., Bridler, R., Cattapan, K., Hartmann, A. M., Rujescu, D., Seifritz, E., Weisbrod, M., & Scharfetter, C. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01918-5 · Cited by 1
Current practice in pharmacological treatment of generalized anxiety disorder
Useinova, A. N., Ayrapetova, A. A., Savshak, M. V., Li, Y. R., Tarusov, N. I., Kondakov, D. M., Boyko, M. V., Solomko, D. V., Seitmemetova, U. M., & Davydova, D. S. (2024) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2407-10 · Cited by 1
Metadata
- Authors
- Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Universidade de São Paulo (BR)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 270-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2477696699
- Semantic Scholar
- 4af046d5cf1f48ed09514ffef416d2de5c0d29cf
- Cited by
- 650
- References
- 251
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 95 · 2023: 84 · 2022: 81 · 2021: 75 · 2020: 55 · 2019: 54 · 2018: 50 · 2017: 38 · 2016: 4
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- newer antidepressants, antidepressant side effects, drug safety, tolerability, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran, vortioxetine, gastrointestinal adverse effects, hepatotoxicity, weight gain, QT prolongation, sexual dysfunction, hyponatremia, osteoporosis, paradoxical effects, suicidality, antidepressant overdose, discontinuation syndrome, pregnancy and lactation, cancer risk, drug selection
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.